Is a complete EVGN research report available?

No complete published report is available for Evogene Ltd. (EVGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Evogene Ltd. (EVGN)

NASDAQ: EVGN · USD

$0.38

+0.01 (+3.9%)· Recorded snapshot

Market cap	6.2M
Revenue (ttm)	1.7M
Net income (ttm)	-9.1M
EPS (ttm)	-$0.86
Shares out	13.5M
Volume	40,104
Beta	0.72

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.7M
Net income (ttm): -9.1M
EPS (ttm): -$0.86
Market cap: 6.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001574565
Company name	Evogene Ltd.
Country	Israel
Country code	US
CUSIP number	M4119S187
Earnings date	2026-11-19
Earnings time	bmo
Employees	52
Employees change	-65
Employees growth	-55.56%
Enterprise value	$8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1999
Industry	Biotechnology
Is primary listing	No
Is SPAC	No
ISIN number	IL0011050551
Last 10-K release date	2026-03-26
Last earnings date	2026-08-18
Last refreshed	2026-10-28
Last stock split date	2024-07-25
Last stock split type	Reverse
Market cap	$6.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-19
Options	No
Price	$0.38
Price currency	USD
Sector	Healthcare
SIC code	2870
Stock price date	2026-10-28
Symbol	EVGN
Website	https://www.evogene.com

Metric

Value

Amount currency

USD

CIK code

0001574565

Company name

Evogene Ltd.

Country

Israel

Country code

CUSIP number

M4119S187

Earnings date

2026-11-19

Earnings time

bmo

Employees

Employees change

-65

Employees growth

-55.56%

Enterprise value

$8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1999

Industry

Biotechnology

Is primary listing

Is SPAC

ISIN number

IL0011050551

Last 10-K release date

2026-03-26

Last earnings date

2026-08-18

Last refreshed

2026-10-28

Last stock split date

2024-07-25

Last stock split type

Reverse

Market cap

$6.2M

Market cap category

Nano-Cap

Next earnings date

2026-11-19

Options

Price

$0.38

Price currency

USD

Sector

Healthcare

SIC code

2870

Stock price date

2026-10-28

Symbol

EVGN

Website

https://www.evogene.com

Metric	Value
Earnings yield	-227.56%
EV/Sales	4.68x
FCF / EV yield	-141.57%
FCF yield	-183.79%
Forward EV/Sales	10.26x
Forward P/S	7.91x
P/B ratio	1.03x
P/S ratio	3.6x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-227.56%

EV/Sales

4.68x

FCF / EV yield

-141.57%

FCF yield

-183.79%

Forward EV/Sales

10.26x

Forward P/S

7.91x

P/B ratio

1.03x

P/S ratio

3.6x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	-67.59%
Operating margin	-858.18%
Pretax margin	-1,000.48%
Profit per employee	$-174,481
Revenue per employee	$31,865
ROA	-37.53%
ROA (5Y)	-26.27%
ROCE	-136.78%
ROE	-182.75%
ROE (5Y)	-69.88%
ROIC	-77.61%
SBC / revenue	18.23%

Metric

Value

Gross margin

-67.59%

Operating margin

-858.18%

Pretax margin

-1,000.48%

Profit per employee

$-174,481

Revenue per employee

$31,865

ROA

-37.53%

ROA (5Y)

-26.27%

ROCE

-136.78%

ROE

-182.75%

ROE (5Y)

-69.88%

ROIC

-77.61%

SBC / revenue

18.23%

Metric	Value
EPS growth quarters	1
EPS growth years	5
Net income growth quarters	1
Net income growth years	4
Revenue growth	-73.1%
Revenue growth (QoQ)	3.89%
Revenue growth 10Y	-15.95%
Revenue growth 3Y	-11.87%
Revenue growth 5Y	7.86%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-73.1%

Revenue growth (QoQ)

3.89%

Revenue growth 10Y

-15.95%

Revenue growth 3Y

-11.87%

Revenue growth 5Y

7.86%

Revenue growth years

Metric	Value
Capital expenditures	$-24,000
Depreciation and amortization	$351,000
EBIT	$-14.2M
EBITDA	$-13.9M
EPS	$-0.86
FCF per share	$-0.81
Financing cash flow	$-9.4M
Free cash flow	$-11M
Free cash flow minus SBC	$-11.3M
Gross profit	$-1.1M
Investing cash flow	$21.3M
Net borrowing	$-511,000
Net cash flow	$987,000
Net income	$-9.1M
Operating cash flow minus SBC	$-11.2M
Operating income	$-14.2M
Revenue	$1.7M
Stock-based compensation	$302,000

Metric

Value

Capital expenditures

$-24,000

Depreciation and amortization

$351,000

EBIT

$-14.2M

EBITDA

$-13.9M

EPS

$-0.86

FCF per share

$-0.81

Financing cash flow

$-9.4M

Free cash flow

$-11M

Free cash flow minus SBC

$-11.3M

Gross profit

$-1.1M

Investing cash flow

$21.3M

Net borrowing

$-511,000

Net cash flow

$987,000

Net income

$-9.1M

Operating cash flow minus SBC

$-11.2M

Operating income

$-14.2M

Revenue

$1.7M

Stock-based compensation

$302,000

Metric	Value
Altman Z-Score	-32.17
Book value per share	$-0.24
Debt / equity	0.36
Long-term assets	$2.6M
Long-term liabilities	$4.6M
Net cash (debt)	$7.2M
Net cash / market cap	120.87%
Net cash growth	-20.12%
Net debt / equity	-1.25
Piotroski F-Score	1
Property, plant and equipment	$2.1M
Shareholders' equity	$5.8M
Tangible book value	$-3.3M
Tangible book value per share	$-0.24
Total assets	$13.4M
Total cash	$9.3M
Total debt	$2.1M
Total liabilities	$7.7M
WACC	6.06%

Metric

Value

Altman Z-Score

-32.17

Book value per share

$-0.24

Debt / equity

0.36

Long-term assets

$2.6M

Long-term liabilities

$4.6M

Net cash (debt)

$7.2M

Net cash / market cap

120.87%

Net cash growth

-20.12%

Net debt / equity

-1.25

Piotroski F-Score

Property, plant and equipment

$2.1M

Shareholders' equity

$5.8M

Tangible book value

$-3.3M

Tangible book value per share

$-0.24

Total assets

$13.4M

Total cash

$9.3M

Total debt

$2.1M

Total liabilities

$7.7M

WACC

6.06%

Metric	Value
Asset turnover	0.07
Current assets	$10.9M
Current liabilities	$3M
Current ratio	3.57
Inventory turnover	2.71
Net working capital	$-838,000
Quick ratio	3.23
Working capital	$7.8M
Working capital turnover	0.16

Metric

Value

Asset turnover

0.07

Current assets

$10.9M

Current liabilities

$3M

Current ratio

3.57

Inventory turnover

2.71

Net working capital

$-838,000

Quick ratio

3.23

Working capital

$7.8M

Working capital turnover

0.16

Metric	Value
Buyback yield / dilution	-51.18%
Dividend yield	0%
Shareholder yield	-51.18%

Metric

Value

Buyback yield / dilution

-51.18%

Dividend yield

Shareholder yield

-51.18%

Metric	Value
10Y price change	-99.38%
10Y return CAGR	-39.87%
10Y total return	-99.38%
150-day SMA	$0.58
15Y price change	-99.05%
15Y return CAGR	-26.7%
15Y total return	-99.05%
1D price change	3.9%
1M price change	-9.07%
1M total return	-9.07%
1W price change	2.05%
1W total return	2.05%
1Y price change	-70.24%
1Y return CAGR	-70.26%
1Y total return	-70.24%
20-day SMA	$0.39
200-day SMA	$0.67
3M price change	-27.31%
3M total return	-27.31%
3Y price change	-92.05%
3Y return CAGR	-56.98%
3Y total return	-92.05%
50-day SMA	$0.46
50-day SMA vs 200-day SMA	50under200
52-week high	$1.33
52-week high date	2025-10-29
52-week low	$0.35
52-week low date	2026-10-19
5Y price change	-98.52%
5Y return CAGR	-56.93%
5Y total return	-98.52%
6M price change	-51.54%
6M total return	-51.54%
All-time high	$203.90
All-time high date	2013-12-12
All-time low	$0.35
All-time low date	2026-10-19
Average true range (ATR)	$0.03
Average volume	151.4K
Beta (5Y)	0.72
Change from 52-week high	-71.58%
Change from 52-week low	9.5%
Change from all-time high	-99.81%
Change from all-time low	9.5%
Change from open	0.77%
Day's gap	3.11%
Dollar volume	$15,159
High price	$0.38
Low price	$0.36
Monthly RSI	30.87
Open price	$0.38
Position in 52-week range	100%
Premarket change	8.58%
Premarket close	$0.36
Premarket price	$0.40
Previous close	$0.36
Price vs 150-day SMA	-35.16%
Price vs 20-day SMA	-2.88%
Price vs 200-day SMA	-43.62%
Price vs 50-day SMA	-17.3%
Relative volume	0.27
RSI	42.41
Sharpe ratio	-1.22
Sharpe ratio (3Y)	-0.49
Sharpe ratio (5Y)	-0.58
Sortino ratio	-1.72
Sortino ratio (3Y)	-0.81
Sortino ratio (5Y)	-0.91
Volume	40.1K
Weekly RSI	33.56
YTD price change	-65.64%
YTD total return	-65.64%

Metric

Value

10Y price change

-99.38%

10Y return CAGR

-39.87%

10Y total return

-99.38%

150-day SMA

$0.58

15Y price change

-99.05%

15Y return CAGR

-26.7%

15Y total return

-99.05%

1D price change

3.9%

1M price change

-9.07%

1M total return

-9.07%

1W price change

2.05%

1W total return

2.05%

1Y price change

-70.24%

1Y return CAGR

-70.26%

1Y total return

-70.24%

20-day SMA

$0.39

200-day SMA

$0.67

3M price change

-27.31%

3M total return

-27.31%

3Y price change

-92.05%

3Y return CAGR

-56.98%

3Y total return

-92.05%

50-day SMA

$0.46

50-day SMA vs 200-day SMA

50under200

52-week high

$1.33

52-week high date

2025-10-29

52-week low

$0.35

52-week low date

2026-10-19

5Y price change

-98.52%

5Y return CAGR

-56.93%

5Y total return

-98.52%

6M price change

-51.54%

6M total return

-51.54%

All-time high

$203.90

All-time high date

2013-12-12

All-time low

$0.35

All-time low date

2026-10-19

Average true range (ATR)

$0.03

Average volume

151.4K

Beta (5Y)

0.72

Change from 52-week high

-71.58%

Change from 52-week low

9.5%

Change from all-time high

-99.81%

Change from all-time low

9.5%

Change from open

0.77%

Day's gap

3.11%

Dollar volume

$15,159

High price

$0.38

Low price

$0.36

Monthly RSI

30.87

Open price

$0.38

Position in 52-week range

100%

Premarket change

8.58%

Premarket close

$0.36

Premarket price

$0.40

Previous close

$0.36

Price vs 150-day SMA

-35.16%

Price vs 20-day SMA

-2.88%

Price vs 200-day SMA

-43.62%

Price vs 50-day SMA

-17.3%

Relative volume

0.27

RSI

42.41

Sharpe ratio

-1.22

Sharpe ratio (3Y)

-0.49

Sharpe ratio (5Y)

-0.58

Sortino ratio

-1.72

Sortino ratio (3Y)

-0.81

Sortino ratio (5Y)

-0.91

Volume

40.1K

Weekly RSI

33.56

YTD price change

-65.64%

YTD total return

-65.64%

Metric	Value
Float	14.5M
Float percentage	106.8%
Shares change (QoQ)	25.28%
Shares change (YoY)	51.18%
Shares held by insiders	8.51%
Shares held by institutions	5.57%
Shares outstanding	13.5M
Short % of shares	5.94%
Short ratio	0.3 days

Metric

Value

Float

14.5M

Float percentage

106.8%

Shares change (QoQ)

25.28%

Shares change (YoY)

51.18%

Shares held by insiders

8.51%

Shares held by institutions

5.57%

Shares outstanding

13.5M

Short % of shares

5.94%

Short ratio

0.3 days

Evogene Ltd. (EVGN)

Price

Financial snapshot

Fair-value bridge

Latest news · EVGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EVGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EVGN

Frequently asked questions